To ask the Scottish Executive whether NHS QIS has made any recommendation about the use of Sutent as a treatment for renal cancer and, if so, what recommendation it has made. The Scottish Medicines Consortiumnoted this month that Sutent ® (sunitinib) is not recommended for use within NHSScotland for the treatment of advanced or metastatic renal cell carcin...